@Article{info:doi/10.2196/19781,
author="Mazoteras-Pardo, Victoria
and Becerro-De-Bengoa-Vallejo, Ricardo
and Losa-Iglesias, Marta Elena
and Mart{\'i}nez-Jim{\'e}nez, Eva Mar{\'i}a
and Calvo-Lobo, C{\'e}sar
and Romero-Morales, Carlos
and L{\'o}pez-L{\'o}pez, Daniel
and Palomo-L{\'o}pez, Patricia",
title="QardioArm Blood Pressure Monitoring in a Population With Type 2 Diabetes: Validation Study",
journal="J Med Internet Res",
year="2020",
month="Jul",
day="24",
volume="22",
number="7",
pages="e19781",
keywords="blood pressure; hypertension; type 2 diabetes; mobile applications; software validation",
abstract="Background: Home blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes. Objective: The purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension. Methods: The sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices. Results: The analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes. Conclusions: This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension. ",
issn="1438-8871",
doi="10.2196/19781",
url="http://www.jmir.org/2020/7/e19781/",
url="https://doi.org/10.2196/19781",
url="http://www.ncbi.nlm.nih.gov/pubmed/32706672"
}